Filing Details
- Accession Number:
- 0001438133-21-000228
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-09 16:24:10
- Reporting Period:
- 2021-12-07
- Accepted Time:
- 2021-12-09 16:24:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1438133 | Tandem Diabetes Care Inc | TNDM | Surgical & Medical Instruments & Apparatus (3841) | 204327508 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1866283 | Anne Elizabeth Gasser | C/O Tandem Diabetes Care, Inc. 11075 Roselle Street San Diego CA 92121 | Evp, Chief Strategy Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-07 | 797 | $89.54 | 1,228 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-12-07 | 286 | $82.34 | 1,514 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-12-07 | 1,083 | $140.00 | 431 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Acquisiton | 2021-12-07 | 797 | $89.54 | 797 | $89.54 |
Common Stock | Stock Option | Acquisiton | 2021-12-07 | 286 | $82.34 | 286 | $82.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
21,514 | No | 4 | M | Direct | ||
8,601 | No | 4 | M | Direct |
Footnotes
- Represents shares of common stock received upon exercise of a stock option award.
- The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021.
- The options vested as to twenty-five (25%) of the underlying shares on 2/18/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
- The expiration date for these options is 10 years from the date of grant.
- The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan.